An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid

Endocrine Journal

Volumn 51, Issue 3, 2004, Pages 355-360

  Chikada, Naoko ^a   Imaki, Toshihiro ^a,b   Hotta, Mari ^c   Sato, Kanji ^a   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c NATIONAL GRADUATE INSTITUTE FOR POLICY STUDIES   (Japan)

Author keywords

Addison's disease; Bone mineral density; Dual X ray absorptiometry; Glucocorticoid; Isolated ACTH deficiency

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; PREDNISOLONE; THYROTROPIN;

ADDISON DISEASE; ADULT; AGE; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN DEFICIENCY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MALE; OSTEOLYSIS; OSTEOPOROSIS;

ADDISON DISEASE; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LEUKOCYTE COUNT; MALE; MIDDLE AGED;

EID: 3242816261     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.51.355     Document Type: Article

References (18)

1. Stewart P (2003) Glucocorticoid deficiency. In: Reed Larsen P, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams Textbook of Endocrinology. Saunders, Philadelphia, 530-533.
2. Burke CW (1992) Primary adrenocortical failure. In: Grossman A (ed) Clinical Endocrinology, Blackwell Scientific Publications, Oxford, 393-404.
3. Florkowski CM, Holmes SJ, Elliot JR, Donald RA, Espiner EA (1994) Bone mineral density is reduced in female but not male subjects with Addison's disease. N Z Med J 107: 52-53.
4. Zelissen PMJ, Croughs RJM, van Rijk PP, Raymakers JA (1994) Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med 120: 207-210.
5. Devogelaer JP, Crabbe J, Nagant de Deuxchaisnes C (1987) Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. Br Med J 294: 798-800.
6. Valero MA, Leon M, Ruiz Valdepenas MP, Larrodera L, Lopez MB, Papapietro K, Jara A, Hawkins F (1994) Bone density and turnover in Addison's disease: effect of glucocorticoid treatment. Bone Mineral 26: 9-17.
7. Braatvedt GD, Joyce M, Evans M, Clearwater J, Reid IR (1999) Bone mineral density in patients with treated Addison's disease. Osteoporosis Int 10: 425-440.
8. Jodar E, Valdepenas MPR, Martinez G, Jara A, Hawkins F (2003) Long-term follow-up of bone mineral density in Addison's disease. Clin Endocrinol 58: 617-620.
9. Peacey SR, Guo C-Y, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP (1997) Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol 46: 225-261.
10. Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WT (1981) Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxford) 14: 451-458.
11. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49: 211-217.
12. Reid IR (1997) Glucocorticoid osteoporosis-mechanisms and management. Eur J Endocrinol 137: 209-217.
13. Nielsen HK, Charles P, Moskilde L (1988) The effect of single oral dose of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab 67: 0125-1030.
14. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral cortisosteroids and risk of fractures. J Bone Miner Res 15: 993-1000.
15. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL (1991) Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 71: 39-45.
16. Lukert BP, Johnson BE, Robinson RG (1992) Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Min Res 7: 1063-1069.
17. Reid FR, Heap SW (1990) Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 150: 2545-2448.
18. Peck W, Gennari C, Rausz KM, Meunier P, Ritz E, Krane S, Nuki R, Avioli LV (1984) Corticosteroids and bone. Calcif Tissue Int 36: 4-7.